23:51 , May 25, 2017 |  BC Extra  |  Company News

Management tracks

Epigenetics play Constellation Pharmaceuticals Inc. (Cambridge, Mass.) named Jigar Raythatha president and CEO. He was CBO at Jounce Therapeutics Inc. (NASDAQ:JNCE), and was previously Constellation's head of corporate development. Former Constellation CEO Keith Dionne has...
07:00 , Oct 10, 2016 |  BC Week In Review  |  Financial News

Probiodrug completes private placement

Probiodrug AG (Euronext:PBD), Halle/Saale, Germany   Business: Neurology   Date completed: 2016-10-06   Type: Private placement   Raised: EUR14.9 million ($16.7 million)   Shares: 744,248   Price: EUR20   Shares after offering: 8.2 million  ...
08:00 , Nov 9, 2015 |  BC Week In Review  |  Financial News

Probiodrug completes private placement

Probiodrug AG (Euronext:PBD), Halle/Saale, Germany   Business: Neurology   Date completed: 2015-11-05   Type: Private placement   Raised: EUR13.5 million ($14.9 million)   Shares: 676,589   Price: EUR20   Shares after offering: 7.4 million  ...
07:00 , Jul 20, 2015 |  BC Week In Review  |  Financial News

Cassiopea completes IPO

Cassiopea S.p.A. (SIX:SKIN), Lainate, Italy   Business: Dermatology, Infectious   Date completed: 2015-07-01   Type: IPO   Raised: CHF175.6 million ($187 million)   Shares: 5.2 million   Price: CHF34   Shares after offering: 10 million...
07:00 , Jun 29, 2015 |  BC Week In Review  |  Financial News

Cassiopea amends IPO

Cassiopea S.p.A. , Lainate, Italy   Business: Dermatology, Infectious   Date announced: 2015-06-22   Type: IPO   To be raised: Up to CHF192 million ($208.6 million)   Shares: 4.8 million   Price: CHF30-CHF40   Underwriters:...
08:00 , Nov 10, 2014 |  BC Week In Review  |  Financial News

Molecular Partners completes IPO

Molecular Partners AG (SIX:MOLN), Schlieren, Switzerland   Business: Ophthalmic, Cancer, Inflammation   Date completed: 2014-11-04   Type: IPO   Raised: CHF96.5 million ($100 million)   Shares: 4.4 million   Price: CHF22.40   Shares after offering:...
03:15 , Nov 6, 2014 |  BC Extra  |  Financial News

IPO roundup: Xenon, Molecular Partners price; Inotek files

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) and Molecular Partners AG (SIX:MOLN) each priced IPOs and began trading, while Inotek Pharmaceuticals Corp. (Lexington, Mass.) filed for a new listing. Xenon gained $1.50 (17%) to $10.50 in its first...
02:15 , Nov 4, 2014 |  BC Extra  |  Financial News

Molecular Partners, Neuroderm set IPO terms

Molecular Partners AG (Schlieren, Switzerland) re-entered the IPO queue with a downsized offering on the SIX Swiss Exchange less than two weeks after postponing the listing due to market conditions, while NeuroDerm Ltd. (Rehovot, Israel)...
07:00 , Oct 27, 2014 |  BC Week In Review  |  Financial News

Molecular Partners postpones IPO

Molecular Partners AG , Schlieren, Switzerland   Business: Ophthalmic, Cancer, Inflammation   Date announced: 2014-10-21   Type: IPO   Underwriters: JPMorgan; UBS; Cowen; Bank am Bellevue   Note: Molecular Partners postponed its IPO on SIX...
07:00 , Sep 29, 2014 |  BC Week In Review  |  Financial News

Molecular Partners proposes IPO

Molecular Partners AG , Schlieren, Switzerland   Business: Ophthalmic, Cancer, Inflammation   Date announced: 2014-09-23   Type: IPO   To be raised: CHF125 million ($133.1 million)   Shares: TBD   Price: TBD   Underwriters: JPMorgan;...